We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors ...
At the moment, RevMed remains keenly focused on its mission to bring daraxonrasib to the masses and continue developing new medicines that target RAS. (Darren Incorvaia) This year’s meeting of the ...
New research shows that crops are far more vulnerable when too much rainfall originates from land rather than the ocean. Land-sourced moisture leads to weaker, less reliable rainfall, heightening ...
Tri-complex inhibitors (TCIs) are molecular glues that bind to active GTP-bound RAS and recruit the intracellular chaperone cyclophilin A (CYPA) to generate a synthetic inhibitory complex that blocks ...
An investigational oral drug that targets RAS, the dominant oncogenic driver in pancreatic cancer, nearly doubled overall survival compared with common second-line chemotherapy regimens in patients ...
Like the engine in your car, your legs have an ideal operating temperature—you don’t need to track a precise number of degrees Fahrenheit, but common sense dictates you shouldn't rev your engine to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results